Small molecule biomarkers, including metabolic signatures, lipids, and steroids, are critical for understanding disease biology and advancing clinical and translational research. However, accurate quantitation of these analytes remains challenging due to their low abundance and the complexity of biological matrices such as plasma, serum, and tissue. SCIEX LC-MS/MS solutions deliver the analytical sensitivity, selectivity, and robustness required to address complex biomarker analysis challenges. Leveraging advanced triple quadrupole and QTRAP technologies, researchers can achieve highly sensitive, reproducible, and multiplexed quantitation across a broad range of small molecule biomarker classes. These capabilities provide the molecular insight needed to uncover novel biomarkers, characterize biological pathways, and support translational research. Integrated workflows spanning sample preparation, data acquisition, and analysis help streamline method development, improve laboratory productivity, and generate high-quality, reproducible data with confidence. By accelerating biomarker discovery, validation, and translation, researchers can move from scientific question to actionable insight faster.


